Article Versions Notes

Gori T, Achenbach S, Riemer T, Mehilli J, Nef HM, Naber C, Richardt G, Wöhrle J, Zahn R, Neumann T, et al. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry. Journal of Clinical Medicine. 2019; 8(6):767. https://doi.org/10.3390/jcm8060767

Gori, Tommaso, Stephan Achenbach, Thomas Riemer, Julinda Mehilli, Holger M. Nef, Christoph Naber, Gert Richardt, Jochen Wöhrle, Ralf Zahn, Till Neumann, and et al. 2019. "Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry" Journal of Clinical Medicine 8, no. 6: 767. https://doi.org/10.3390/jcm8060767

Gori, T., Achenbach, S., Riemer, T., Mehilli, J., Nef, H. M., Naber, C., Richardt, G., Wöhrle, J., Zahn, R., Neumann, T., Kastner, J., Schmermund, A., Hamm, C., & Münzel, T. (2019). Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry. Journal of Clinical Medicine, 8(6), 767. https://doi.org/10.3390/jcm8060767